Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ketamine for major depressive disorder
IRCT2015030921072N2Phase 4Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by Babol University of Medical Sciences. Started Jan 2015; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT2015030921072N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015030921072N2.